MedTrace Logo

Supplemented Very Low Protein Diet and the Progression of Chronic Kidney Disease

NCT02031224 · Status: COMPLETED · Phase: PHASE4 · Type: INTERVENTIONAL · Enrollment: 250

Last updated 2017-12-22

No results posted yet for this study

Summary

This is a prospective single center randomized controlled trial with a total duration of 18 months aiming to evaluate the effectiveness and the safety of a very low protein diet supplemented with ketoanalogues of essential aminoacids in reducing the progression of chronic kidney disease (CKD) in patients with advanced CKD.

Conditions

Interventions

BEHAVIORAL

Conventional low protein diet

DIETARY_SUPPLEMENT

Very low protein diet supplemented with Ketosteril

Sponsors & Collaborators

  • Dr Carol Davila Teaching Hospital of Nephrology Bucharest

    collaborator UNKNOWN

  • Anemia Working Group Romania

    lead OTHER

Principal Investigators

  • Gabriel Mircescu, Prof · Carol Davila University of Medicine and Pharmacy

Study Design

Allocation
RANDOMIZED
Purpose
PREVENTION
Masking
NONE
Model
PARALLEL

Eligibility

Min Age
18 Years
Max Age
85 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2008-03-31
Primary Completion
2014-06-30
Completion
2014-08-31

Countries

  • Romania

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT02031224 on ClinicalTrials.gov